Legislation – The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020

Changes to legislation:

There are currently no known outstanding effects for The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020, Section 24. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

New regulation 291A24.

After regulation 291 (form and content of advertisement) insert—

“Campaigns relating to the suspected or confirmed spread of pathogenic agents etc.291A.

(1)

Regulations 284 (prescription only medicines), 285 (narcotic and psychotropic substances), 287(4)(b) (material about effects of a medicinal product) and 291(2)(d) (form and content of advertisement) do not apply to an advertisement as part of a campaign that—

(a)

relates to the use of a medicinal product in response to the suspected or confirmed spread of—

(i)

pathogenic agents,

(ii)

toxins,

(iii)

chemical agents, or

(iv)

nuclear radiation; and

(b)

has been approved by the Ministers.

(2)

Before approving a campaign that relates to—

(a)

all or any area of Scotland, the Ministers must consult the Scottish Ministers;

(b)

all or any areas of Wales, the Ministers must consult the Welsh Ministers.”.

Annotations:
Commencement Information

I1Reg. 24 in force at 6.11.2020, see reg. 1(2)